Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Sep-23 8:04 PM View:  | Ars Pharmaceuticals, Inc. (SPRY) | 01-Sep-23 | Option Exercise | 100,000 | $1.27 | $127,000.00 | 48% 210.35K to 310.35K | |
| 05-Sep-23 8:04 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 01-Sep-23 | Planned Option Sale | 100,000 | $7.71 | $770,520.00 | (32%) 310.35K to 210.35K | |
| 07-Aug-23 5:05 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 04-Aug-23 | Option Exercise | 18,897 | $1.27 | $23,999.20 | 9% 210.35K to 229.24K | |
| 07-Aug-23 5:05 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 04-Aug-23 | Planned Option Sale | 18,897 | $7.06 | $133,471.00 | (8%) 229.24K to 210.35K | |
| 07-Aug-23 5:05 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 03-Aug-23 | Option Exercise | 26,107 | $1.27 | $33,155.90 | 12% 210.35K to 236.45K | |
| 07-Aug-23 5:05 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 03-Aug-23 | Planned Option Sale | 26,107 | $7.01 | $183,018.00 | (11%) 236.45K to 210.35K | |
| 03-Aug-23 6:03 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 02-Aug-23 | Option Exercise | 36,281 | $1.27 | $46,076.90 | 17% 210.35K to 246.63K | |
| 03-Aug-23 6:03 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 02-Aug-23 | Planned Option Sale | 36,281 | $7.09 | $257,265.00 | (15%) 246.63K to 210.35K | |
| 03-Aug-23 6:03 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 01-Aug-23 | Option Exercise | 18,715 | $1.27 | $23,768.00 | 9% 210.35K to 229.06K | |
| 03-Aug-23 6:03 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 01-Aug-23 | Planned Option Sale | 18,715 | $7.19 | $134,576.00 | (8%) 229.06K to 210.35K | |
| 07-Jul-23 8:16 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 07-Jul-23 | Option Exercise | 8,858 | $1.27 | $11,249.70 | 4% 210.35K to 219.2K | |
| 07-Jul-23 8:16 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 07-Jul-23 | Planned Option Sale | 8,858 | $6.36 | $56,372.30 | (4%) 219.2K to 210.35K | |
| 06-Jul-23 8:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 06-Jul-23 | Option Exercise | 33,510 | $1.27 | $42,557.70 | 16% 210.35K to 243.86K | |
| 06-Jul-23 8:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 06-Jul-23 | Planned Option Sale | 33,510 | $6.34 | $212,554.00 | (14%) 243.86K to 210.35K | |
| 06-Jul-23 8:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 05-Jul-23 | Option Exercise | 31,112 | $1.27 | $39,512.20 | 15% 210.35K to 241.46K | |
| 06-Jul-23 8:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 05-Jul-23 | Planned Option Sale | 31,112 | $6.41 | $199,552.00 | (13%) 241.46K to 210.35K | |
| 06-Jul-23 8:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 03-Jul-23 | Option Exercise | 26,520 | $1.27 | $33,680.40 | 13% 210.35K to 236.87K | |
| 06-Jul-23 8:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 03-Jul-23 | Planned Option Sale | 26,520 | $6.72 | $178,347.00 | (11%) 236.87K to 210.35K | |
| 02-Jun-23 7:48 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 02-Jun-23 | Option Exercise | 26,941 | $1.27 | $34,215.10 | 13% 210.35K to 237.29K | |
| 02-Jun-23 7:48 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 02-Jun-23 | Planned Option Sale | 26,941 | $6.95 | $187,240.00 | (11%) 237.29K to 210.35K | |
| 02-Jun-23 7:48 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 01-Jun-23 | Option Exercise | 73,059 | $1.27 | $92,784.90 | 35% 210.35K to 283.4K | |
| 02-Jun-23 7:48 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 01-Jun-23 | Planned Option Sale | 73,059 | $6.80 | $496,801.00 | (26%) 283.4K to 210.35K | |
| 26-May-23 4:14 PM View: | Relay Therapeutics, Inc. (RLAY) | 24-May-23 | Gift | 12,099 | -- | -- | (23%) 52.1K to 40.0K | |
| 10-May-23 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 09-May-23 | Option Exercise | 42,900 | $1.27 | $54,483.00 | 20% 210.35K to 253.25K | |
| 10-May-23 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 09-May-23 | Sale (Planned) | 42,900 | $5.31 | $227,799.00 | (17%) 253.25K to 210.35K | |
| 10-May-23 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-May-23 | Option Exercise | 57,100 | $1.27 | $72,517.00 | 27% 210.35K to 267.45K | |
| 10-May-23 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-May-23 | Planned Option Sale | 56,104 | $6.16 | $345,601.00 | (21%) 267.45K to 211.34K | |
| 10-May-23 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-May-23 | Sale (Planned) | 996 | $6.16 | $6,135.36 | (< 1%) 211.34K to 210.35K | |
| 10-May-23 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 09-Nov-22 | Option Sale | 43,896 | $4.58 | $201,044.00 | (17%) 254.24K to 210.35K | |
| 09-Aug-22 4:38 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 05-Aug-22 | Option Exercise | 78,740 | $1.27 | $99,999.80 | 45% 175.5K to 254.24K | |
| 04-May-22 5:19 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 02-May-22 | Grant | 68,107 | -- | -- | 63% 107.39K to 175.5K | |
| 02-Feb-22 5:17 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 01-Feb-22 | Grant | 27,500 | -- | -- | 34% 79.89K to 107.39K | |
| 24-Jan-20 6:41 PM View: | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 220,595 | $68.00 | $15,000,500.00 | (90%) 245.59K to 25.0K | |
| 24-Jan-20 6:41 PM View: | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 25,000 | $68.00 | $1,700,000.00 | (100%) 25.0K to 0 | |
| 24-Jan-20 6:41 PM View: | Synthorx, Inc. (THOR) | 08-Jan-20 | Gift | 80,706 | -- | -- | (25%) 321.3K to 240.59K | |
| 02-Jan-20 4:39 PM View: | Synthorx, Inc. (THOR) | 30-Dec-19 | Payment of Exercise | 210,010 | $70.63 | $14,833,000.00 | (40%) 531.31K to 321.3K | |
| 02-Jan-20 4:39 PM View: | Synthorx, Inc. (THOR) | 30-Dec-19 | Option Exercise | 379,453 | $4.02 | $1,525,320.00 | 250% 151.86K to 531.31K | |
| 19-Dec-19 4:41 PM View: | Synthorx, Inc. (THOR) | 18-Dec-19 | Grant | 45,000 | -- | -- | 42% 106.86K to 151.86K | |
| 25-Jan-19 4:33 PM View: | Synthorx, Inc. (THOR) | 24-Jan-19 | Option Exercise | 25,000 | $0.63 | $15,750.00 | 31% 80.71K to 105.71K |